Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI...

by Bramlage P, Mengden T, Hübner
Published 2011-12-01

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

by Seufert J, Pegelow K, Bramlage P
Published 2013-11-01

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Trip...

by Bramlage P, Bonner G, Landers B
Published 2011-02-01

Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study

by Schmieder RE, Goebel M, Bramlage P
Published 2012-03-01

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting G...

by Kress S, Borck A, Zisman A, Bramlage P, Siegmund T
Published 2021-03-01

Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in Switzerland

by Rey A, Thoenes M, Fimmers R, Meier CA, Bramlage P
Published 2012-09-01

Risk Factor Management in Non-Metropolitan Patients with Coronary and Peripheral Artery Disease – A Protocol of a Prospective, Multi-Center, Quality Improvement Strategy

by Zemmrich C, Bramlage P, Hillmeister P, Sacirovic M, Buschmann I
Published 2021-05-01

Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

by Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE
Published 2013-08-01

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

by Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE
Published 2014-12-01

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

by Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T
Published 2014-05-01

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

by Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM
Published 2014-05-01